Zaurategrast
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2007 (NCT00484536)
Timeline
Indications
Mechanism of action
- Integrin alpha-4INHIBITOR
ITGA4 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- cdp323
- cdp323
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00726648 | Phase 1/Phase 2 (Phase 2) | Jul 1, 2008 | Biogen, Hoosier Cancer Research Network |
| NCT00484536 | Phase 2 | May 1, 2007 | Biogen, Hoosier Cancer Research Network |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Biogen | For profit | 2 | 0 | 1 | 2007 |
| Hoosier Cancer Research Network | Academic/Hospital | 2 | 2 | 1 | 2007 |
2 organizations
Page 1 / 1